El Camino Hospital Respiragene Trial Video News Clip

Video news link explaining El Camino trial

AACR Feature: Genetic test may help target lung cancer CT screening (Healthimaging.com)

A gene-based test that estimates lung cancer risk may help identify which smokers are most likely to benefit from CT screening for lung cancer, according to a study presented at the American Association of Cancer Research (AACR) annual conference on Nov. 9.

El Camino Hospital Physicians Launch Trial (with RespirageneTM) to Find Early Diagnosis Tool for Lung Cancer (Enhanced Online News)

MOUNTAIN VIEW, Calif.--(EON: Enhanced Online News)--Physicians at El Camino Hospital are starting a medical trial called REACT that they hope may give doctors a new and cost-effective tool for early diagnosis of lung cancer, the deadliest of the common cancers.

Only one way to cut lung cancer risk (New Zealand Herald)

Tobacco use and nicotine addiction are enormously important public health issues that warrant a broad-based counterattack.

Let's Talk About Smoking and Cancer (Caring.com)

Quitting Is Best, But There Are Other Ways To Protect Yourself and Your Family Members

Synergenz reviews “Questioning a Cancer Test”, a New York Times article (November 7, 2009) about RespirageneTM

Christopher Taylor's story tells it all. Here is a man who smoked but wanted to quit. Like many smokers, Taylor was interested in better understanding his own risk profile for lung cancer throug...

Gauging the Risks From a Smoker’s DNA and History (The New York Times)

To take Synergenz’s RespirageneTM test, consumers swab the inside of a cheek to get DNA and send the sample to a laboratory in Kentucky.

Questioning a Test for Lung Cancer (The New York Times)

Christopher Taylor says he never lasted more than a week when he tried to quit smoking in the past. But it has been four weeks and counting this time, since a genetic test indicated he had a much higher risk of developing lung cancer than the average smoker.

The RespirageneTM genetic test for smokers: the company sets out its evidence (The Times, UK)

A week ago, Hannah wrote a piece (and I wrote a commentary) about RespirageneTM -- a new test that claims to assess smokers' genetic risk of developing lung cancer.

Molecular Diagnostics Laboratories launches gene-based test for lung cancer predisposition (WCPO)

Molecular Diagnostics Laboratories launches gene-based test for lung cancer predisposition

Can a Genetic Test of Lung Cancer Risk Help Smokers Quit? (RT Magazine)

In a presentation at the 3rd Smoking Cessation Conference in Philadelphia, W. Jeffrey Allard, PhD, clinical affairs director of Synergenz Bioscience Ltd, told listeners that smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit.

RespirageneTM test for lung cancer motivates smokers to quit smoking (The Medical News)

Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.

PHD Diagnostics Develops Gene-Based Test to Predict Smokers’ Lung Cancer Risk, (Genetic Engineering and Biotechnology News)

PHD Diagnostics and its CLIA-certified lab, Molecular Diagnostics Laboratories, have developed a genetic test called Respiragene™ that identifies smokers and ex-smokers at the greatest risk of developing lung cancer.

A Small Light is Flickering at the End of the Lung Cancer Tunnel

What if I told you that there is a test that has recently been developed and tested and that with a simple questioner, and a swab of the inside of your mouth,you will know your future as far as lung cancer is concerned. You could alter your own fate; spare your family and friends the anguish that is a part of treatment that comes along with lung cancer.

Genetic Testing In N.Ky. Helps Smokers Quit (The Kentucky Post)

A group of high-tech businesses have now opened under one roof in Northern Kentucky with a focus on improving your health.

Beshear Cuts Ribbon on Life Science Accelerator Building (The Kentucky Post)

Gov. Steve Beshear Thursday joined state and local officials to mark the opening of a life science accelerator building that provides offices and laboratory space for start-up biotechnology companies developing anti-cancer drugs, genetic tests and medical instruments.

£300 DNA test could save smokers' lives (The Sun, United Kingdom)

THOUSANDS of smokers could be saved by a new £300 DNA test which rates their chances of getting lung cancer.

Un test ADN pour évaluer les risques de cancer du poumon (Le Figaro, France)

Mesurer à l'aide d'un test salivaire la probabilité pour un fumeur ou un ex-fumeur de développer un cancer des poumons, c'est ce que promet une équipe de chercheurs néo-zélandais de...

First gene-based test to predict individual lung cancer risk (Insciences, Switzerland)

A gene-based test is now available to identify smokers and ex-smokers at greatest risk of getting lung cancer.